Literature DB >> 2857462

Encephalopathy associated with ifosphamide/mesna therapy.

C A Meanwell, A E Blake, T N Latief, G Blackledge, J J Mould, D R Blake, I C Shaw, L Honigsberger, D Spooner, A C Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857462     DOI： 10.1016/s0140-6736(85)91432-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Disposition of ifosfamide in patients receiving ifosfamide infusion therapy for the treatment of cervical carcinoma.

Authors:  R Pearcey; R Calvert; A Mehta
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.

Authors:  R E Coleman; J M Clarke; M L Slevin; J Sweetenham; C J Williams; P Blake; F Calman; E Wiltshaw; P G Harper
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Toxicity of high-dose ifosfamide in children.

Authors:  S M Davies; A D Pearson; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.

Authors:  P C Lara; J L Garcia-Puche; V Pedraza
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

Authors:  Bernd Kasper; Christoph Harter; Julia Meissner; Frauke Bellos; Fatime Krasniqi; Anthony D Ho; Gerlinde Egerer
Journal:  Support Care Cancer       Date:  2004-01-16       Impact factor: 3.603

Review 6.  Dosing and side-effects of ifosfamide plus mesna.

Authors:  W P Brade; K Herdrich; U Kachel-Fischer; C E Araujo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix.

Authors:  R E Coleman; P G Harper; C Gallagher; R Osborne; E M Rankin; A C Silverstone; M L Slevin; R L Souhami; J S Tobias; C W Trask
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 8.  Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Authors:  Karen I Sweiss; Rakesh Beri; Stacy S Shord
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 9.  The glycine deportation system and its pharmacological consequences.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

10.  A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.

Authors:  B M Cantwell; J Carmichael; S Ghani; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.